In blow to the fur industry, EU bans breeding and keeping of American mink

A close up photo of a mink in a dirty cage

Date: July 22, 2025

Author(s): Kitty Block

In the early 20th century, the American mink was introduced to Europe for fur farming, and, in some cases, deliberately released into the wild for hunters. Eventually, millions of American mink established populations in the wild and thrived across Europe.  

Last week, the European Union officially added the non-native American mink to its list of Invasive Alien Species of Union Concern. This means that keeping and breeding American mink is banned starting July 2027. This is major news, as this designation should effectively ban mink fur farming across the EU. But will it? 

The end of this cruel industry could not come fast enough. Fur factory farms confine millions of wild animals in small, wire-bottomed cages. They live their whole lives unable to engage in natural behaviors—such as running, digging and, in the case of mink, swimming—and they are killed by gassing, electrocution or bludgeoning.  

Under the new regulation, EU Member States will be required to prohibit the breeding, sale, keeping, transport and release of American mink. They will also be required to support fur farmers in transition away from the industry through compensation, training and reemployment programs. 

But there’s a catch: Mink fur farming could continue if the European Commission allows Member States to issue permits to fur farmers under a derogation in the EU’s Invasive Alien Species Regulation—that is, a loophole that would sidestep the ban on keeping American mink as an invasive species.  

Unfortunately, we have seen this happen before. The raccoon dog was added to the IAS list in 2019; Finland and Poland were granted an authorization for 30 years to allow raccoon dog fur farming to continue, despite overwhelming evidence of the ecological threat posed. So, while the regulation could help accelerate the closure of fur farms in some countries, others—such as Denmark, Greece and Finland—could seek to undermine the ban by requesting to continue mink farming under exemptions.  

That’s why we are urging the Commission to reject industry attempts to sidestep a mink ban and instead to introduce an EU-wide fur farming ban for all species in the fur trade. This would be in line with the 1.5 million signatures on the European Citizens Initiative petition calling for a complete ban. 

Twenty-two European countries, including 16 Member States, have already banned fur farming, including most recently Estonia, Latvia, Lithuania and Romania; and though there is no official ban in Sweden or Bulgaria, there are no more active fur farms there. But in the European countries where fur farming is not banned, nearly 6 million American mink are still being kept on fur farms, in countries such as Poland, Spain, Finland, Greece and Denmark.  

Fur farming is an ethical and environmental disgrace. There is no place for it in the humane world that millions of us are striving to create.  

New study advances theory on why most U.S. bird flu cases have so far been mild

Researchers believe immunity to an earlier virus may play a role, but not everyone agrees

A new study used ferrets, the closest animal model for what happens when humans are infected with influenza, to investigate why many human cases of H5N1 bird flu have been mild.Adobe

By Helen Branswell

July 23, 2025

Helen Branswell, STAT’s senior writer on infectious disease, has been reporting on H5N1 bird flu for 20 years.

The H5N1 bird flu virus has historically extracted a heavy toll when it infects humans, with nearly half of confirmed cases ending in death over the past three decades. But of the 70 cases reported in the United States over the past 18 months, only a single death occurred, leaving experts puzzled at how to explain the phenomenon.

A new study published Wednesday adds weight to an argument that the immunity people have developed to the virus that caused the most recent flu pandemic, an H1N1 virus that emerged in 2009, has induced some cross-protection that may be making it harder for H5N1 to infect people, and mitigating the severity of the ensuing disease when such infections occur.

Advertisement

The paper, published in the journal Science Translational Medicine, reports on a number of studies done in ferrets, the closest animal model for what happens when humans are infected with influenza. It showed that while H5N1 is lethal to ferrets with no immunity to influenza, animals that have previously been infected with influenza A — either H3N2 or H1N1 — appear to have some protection when they are later exposed to the bird flu virus. The protection is particularly strong with H1N1.

https://buy.tinypass.com/checkout/offer/show?displayMode=inline&containerSelector=.the-content%20%3E%20p%3Anth-of-type(4)&templateId=OTEDNDT7NLVV&templateVariantId=OTVKDP4RUQE88&offerId=OFHDKDJ82C5T&formNameByTermId=%7B%7D&hideCompletedFields=true&showCloseButton=false&experienceActionId=showOfferX89QKMZKAZZZ91&offerType=purchase&experienceId=EXYTTUDE8KPN&activeMeters=%5B%7B%22meterName%22%3A%22Regwall%22%2C%22views%22%3A1%2C%22viewsLeft%22%3A0%2C%22maxViews%22%3A1%2C%22totalViews%22%3A2%7D%5D&companyName=public%20utility%20district%20no.%201%20of%20okanogan%20county&sessions=&widget=offer&iframeId=offer-0-ZcU61&url=https%3A%2F%2Fwww.statnews.com%2F2025%2F07%2F23%2Fh5n1-bird-flu-immunity-boosted-by-previous-influenza-a-infection%2F&parentDualScreenLeft=0&parentDualScreenTop=0&parentWidth=1536&parentHeight=714&parentOuterHeight=816&aid=3FPRsl3Rpu&customVariables=%7B%22browser_name%22%3A%22Edge%22%2C%22browser_is_private%22%3A%22no%22%2C%22asset_type%22%3A%22story%20page%22%2C%22primary_category%22%3A%22in-the-lab%22%2C%22is_paywalled%22%3A%22no%22%7D&browserId=mdevgflecvwr9x2c&userState=anon&pianoIdUrl=https%3A%2F%2Fid.piano.io%2Fid%2F&userProvider=piano_id_lite&userToken=&customCookies=%7B%7D&hasLoginRequiredCallback=true&initMode=context&abTestIds=%5B%22splitTestVariant0QK3L9L10NO7493%22%5D&requestUserAuthForLinkedTerm=true&initTime=9883.200000047684&logType=offerShow&width=674&_qh=9f6fe40e62

Newsletter

Understand how science, health policy, and medicine shape the world every daySign Up

Advertisement

Most Popular

  1. STAT goes on a MAHA food crawl
  2. Kentucky’s campaign to improve rural cancer care is a national model. Federal cuts threaten its progress
  3.  Solid tumors have challenged CAR-T developers. This biotech raised $216 million to test a new approach
  4. https://2a808f728e385da2176442703df690ad.safeframe.googlesyndication.com/safeframe/1-0-45/html/container.html
  5. Researchers sequence complex parts of human genome, expanding the future of precision medicine

Reports 

From insurer to industry titan: Inside UnitedHealth’s empire

Advertisement

Health

HHS Secretary RFK Jr. accepts recommendations to drop thimerosal from U.S. flu vaccines

By Helen Branswell

In the Lab

Researchers sequence complex parts of human genome, expanding the future of precision medicine

By Veronica Paulus

Advertisement

The Readout

  STAT Plus:FDA opens applications for new voucher program 

By Elaine Chen

AI Prognosis

  STAT Plus:What’s hot in health AI investing, what’s not…and what’s venture capital?

By Brittany Trang

Morning Rounds

  STAT Plus:What happens to daily methadone treatment in a climate disaster?

By Theresa Gaffney

  1.  STAT Plus:The crisis over Sarepta’s Duchenne therapy is a mess. But the lesson is clearBy Matthew Herper
  2.  STAT Plus:Senators reveal how much Lilly, Pfizer paid telehealth companiesBy Katie Palmer
  3.  STAT Plus:Undruggable ‘disordered’ proteins become druggable with new AI techniques from David BakerBy Brittany Trang
  4.  STAT Plus:Sarepta Therapeutics crisis is huge blow to Duchenne families, companyBy Jason Mast and Adam Feuerstein
  5.  STAT Plus:Medicare plans to cover more than a thousand new procedures in outpatient settings, despite concerns about safetyBy Tara Bannow
Daily Recap

  Industry Academia Advertising/Communications Agency Advocacy/Non-Profit Banking Biotech Clinical Research Organization Consulting Firm Consumer Health Financial Services (Other) Government Healthcare Payer/Insurance Health Tech Hospital Systems/Provider Law Media Medical Devices Medical Technology Pharmaceuticals Pharmacy/Retail Real Estate Trade Association Technology Venture Capital Other (Please Specify)